~9 spots leftby Apr 2026

Bilateral Treatment of Medication Refractory Essential Tremor

Recruiting in Palo Alto (17 mi)
+6 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: InSightec
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to see if the MR-guided focused ultrasound (MRgFUS) thalamotomy procedure can be performed on both sides of the brain safely and effectively to reduce bilateral tremor.

Eligibility Criteria

Inclusion Criteria

Men and women age 22 years or older
You have Essential Tremor that does not respond to medication.
You are able to tell the doctors how you feel during the Exablate thalamotomy procedure.
See 1 more

Exclusion Criteria

Unstable cardiac status
Has experienced any non-transient neurological event or worsening following the Exablate index procedure
Non-transient hemiparesis as determined by physical examination
See 13 more

Treatment Details

Interventions

  • MR-guided focused ultrasound thalamotomy (Focused Ultrasound)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Exablate Secondary ProcedureExperimental Treatment1 Intervention
Thalamotomy

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of PennsylvaniaPhiladelphia, PA
Stanford University, School of MedicineStanford, CA
University of MarylandBaltimore, MD
University of VirginiaCharlottesville, VA
More Trial Locations
Loading ...

Who Is Running the Clinical Trial?

InSightecLead Sponsor

References